Top 10 Companies in the China Milk of Magnesia Market (2026): Market Leaders Shaping Digestive Health Trends

The China Milk of Magnesia market size was valued at USD 123.7 million in 2025 and is projected to reach USD 158.4 million by 2034, at a CAGR of 4.2% during the forecast period 2025-2034.

China Milk of Magnesia Market – View in Detailed Research Report

Milk of Magnesia is a suspension of magnesium hydroxide in water, used as an antacid and laxative in over-the-counter medications.
China’s Milk of Magnesia market is growing steadily, driven by increasing awareness of digestive health, expanding over-the-counter medication market, and ongoing product innovations in antacid formulations. In 2023, total production reached 12,000 metric tons, with antacid applications accounting for 70% of market value. The market saw a 5% increase in demand for flavored milk of magnesia products in 2023, improving palatability and patient compliance. Use in cosmetic and personal care products is growing at 6% annually, albeit from a small base. The market is witnessing a trend towards combination products, with an 8% year-over-year increase in R&D investments for milk of magnesia formulations containing additional active ingredients. Adoption of sugar‑free and low‑sodium variants grew by 10% in 2023. Key manufacturers are focusing on developing milk of magnesia with improved stability and shelf life, with a 12% increase in efforts to enhance packaging and formulation technologies. The industry is also seeing increased interest in milk of magnesia as a component in specialty oral care products, with a 15% rise in new product launches featuring milk of magnesia for sensitive teeth and dry mouth relief.

🔟 1. Harbin Pharmaceutical Group Holding Co., Ltd.

Headquarters: Harbin, China
Key Offering: Milk of Magnesia antacid and laxative tablets, flavored sachets, and low‑sodium formulations

Harbin Pharmaceutical has maintained a dominant share of the Chinese OTC market through a broad product portfolio and extensive distribution network. In 2023, the company reported a 9% rise in sales volume of milk of magnesia products, driven by a strategic push into rural pharmacies and e‑commerce platforms.

Growth Initiatives:

• Investing 8% of annual revenue in R&D for sugar‑free and low‑sodium variants
• Expanding shelf‑life through advanced encapsulation technologies
• Launching a subscription‑based home‑delivery service for chronic constipation patients

---

9️⃣ 2. Shanghai Pharmaceuticals Holding Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Milk of Magnesia capsules, flavored sachets, and oral care adjuncts

Shanghai Pharmaceuticals leverages its extensive research arm to introduce combination products that pair milk of magnesia with herbal digestive aids. The company’s 2023 revenue from the segment grew 7% year‑over‑year, reflecting successful cross‑marketing with its gastrointestinal drug line.

Growth Initiatives:

• Partnerships with leading dental associations to promote oral care formulations
• Investment in cold‑chain logistics to support high‑quality product delivery in northern provinces
• Development of a mobile app for patient education and dosage reminders

---

8️⃣ 3. Sinopharm Group Co. Ltd.

Headquarters: Beijing, China
Key Offering: Milk of Magnesia tablets, flavored sachets, and specialty oral care products

Sinopharm’s market presence is amplified by its national distribution network, covering both urban and rural outlets. The 2023 segment revenue increased 6%, propelled by a new line of low‑sodium milk of magnesia tailored for patients with hypertension.

Growth Initiatives:

• Collaboration with local health authorities to promote preventive digestive care
• Expansion of packaging innovation to include biodegradable sachets
• Strategic alliances with e‑commerce giants for last‑mile delivery

---

7️⃣ 4. Bayer China

Headquarters: Shanghai, China
Key Offering: Milk of Magnesia capsules, flavored sachets, and OTC combination therapies

Bayer China focuses on integrating milk of magnesia into broader gastrointestinal therapy lines. In 2023, the company reported a 5% increase in sales volume, supported by a new marketing campaign highlighting digestive health during the annual health awareness month.

Growth Initiatives:

• Investment in AI‑driven demand forecasting for OTC products
• Launch of a joint venture with a local biotech firm for novel active‑ingredient combinations
• Enhanced digital marketing through influencer partnerships

---

6️⃣ 5. Jiangsu Hengrui Medicine Co., Ltd.

Headquarters: Nanjing, China
Key Offering: Milk of Magnesia tablets, flavored sachets, and specialized oral care solutions

Hengrui’s product line benefits from a strong R&D pipeline, delivering new formulations that target both constipation and gastric discomfort. The 2023 revenue growth of 7% reflects the company’s focus on product differentiation.

Growth Initiatives:

• Development of a high‑potency, low‑volume sachet for rapid relief
• Expansion into the ASEAN market through regional distributors
• Investment in sustainable packaging to reduce environmental footprint

---

5️⃣ 6. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

Headquarters: Guangzhou, China
Key Offering: Milk of Magnesia capsules, flavored sachets, and OTC combination products

Guangzhou Baiyunshan has built a reputation for high‑quality, affordable OTC medicines. In 2023, the company’s milk of magnesia segment grew 8% in sales volume, driven by aggressive pricing and expanded retail presence.

Growth Initiatives:

• Launch of a line of sugar‑free sachets to cater to diabetic consumers
• Partnership with local health insurance providers for patient subsidies
• Implementation of blockchain for supply‑chain transparency

---

4️⃣ 7. Zhejiang Medicine Co., Ltd.

Headquarters: Hangzhou, China
Key Offering: Milk of Magnesia tablets, flavored sachets, and oral care adjuncts

Zhejiang Medicine’s focus on product stability has led to a 9% increase in 2023 sales volume, supported by a new line of preservative‑free sachets aimed at the health‑conscious consumer.

Growth Initiatives:

• Investment in nanotechnology for improved dissolution rates
• Strategic collaboration with e‑commerce platforms for targeted marketing
• Development of a mobile app for dosage guidance and patient feedback

---

3️⃣ 8. China Resources Pharmaceutical Group

Headquarters: Guangzhou, China
Key Offering: Milk of Magnesia tablets, flavored sachets, and specialty oral care products

China Resources Pharmaceutical has leveraged its extensive retail network to capture a significant share of the OTC market. The 2023 segment revenue rose 6%, fueled by a new line of low‑sodium, sugar‑free sachets.

Growth Initiatives:

• Expansion of production capacity by 15% to meet rising demand
• Investment in AI for personalized dosage recommendations
• Partnership with dental clinics for oral care product promotion

---

2️⃣ 9. Livzon Pharmaceutical Group Inc.

Headquarters: Xiamen, China
Key Offering: Milk of Magnesia tablets, flavored sachets, and OTC combination therapies

Livzon’s focus on innovation has positioned it as a key player in the market. In 2023, the company reported a 10% increase in sales volume, driven by the launch of a new line of flavored, low‑sodium sachets.

Growth Initiatives:

• Investment in green chemistry to reduce environmental impact of production
• Expansion of the online sales channel to reach younger consumers
• Collaboration with health‑tech startups for digital health integration

---

1️⃣ 10. Sino Biopharmaceutical Ltd.

Headquarters: Shanghai, China
Key Offering: Milk of Magnesia tablets, flavored sachets, and specialty oral care adjuncts

Sino Biopharmaceutical has carved out a niche in the specialty oral care segment, with its milk of magnesia products targeting sensitive teeth and dry mouth relief. The 2023 revenue for this segment grew 12%, reflecting strong consumer demand.

Growth Initiatives:

• Launch of a line of probiotic‑infused milk of magnesia sachets for digestive health
• Strategic partnership with dental associations for product endorsement
• Investment in smart packaging to monitor product integrity

---

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/280480/china-milk-of-magnesia-market-market-814

Get Full Report Here: https://www.24chemicalresearch.com/reports/280480/china-milk-of-magnesia-market-market-814

Outlook: The Future of Milk of Magnesia in China Is Health‑Focused and Innovation‑Driven

As consumers increasingly prioritize digestive wellness, the Milk of Magnesia market is poised for steady expansion. Key drivers include the growing prevalence of chronic constipation, rising disposable income, and a shift toward personalized OTC solutions. The segment is also benefiting from regulatory support for low‑sodium, sugar‑free formulations, which align with national nutrition guidelines.

Future Trends Shaping the Market

• Growth of digital health platforms for OTC medication guidance
• Expansion of flavor profiles to enhance patient compliance
• Integration of milk of magnesia into multi‑symptom digestive care kits
• Adoption of smart packaging to monitor dosage and shelf life
• Increased focus on sustainability in packaging and production processes